Gene: USP11
Official Full Name: ubiquitin specific peptidase 11provided by HGNC
Gene Summary: Protein ubiquitination controls many intracellular processes, including cell cycle progression, transcriptional activation, and signal transduction. This dynamic process, involving ubiquitin conjugating enzymes and deubiquitinating enzymes, adds and removes ubiquitin. Deubiquitinating enzymes are cysteine proteases that specifically cleave ubiquitin from ubiquitin-conjugated protein substrates. This gene encodes a deubiquitinating enzyme which lies in a gene cluster on chromosome Xp11.23 [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00505 | USP11 Knockout cell line (A549) | Human | USP11 | 1:3~1:4 | Negative | Online Inquiry |
KO04962 | USP11 Knockout cell line (HeLa) | Human | USP11 | 1:3~1:6 | Negative | Online Inquiry |
KO04963 | USP11 Knockout cell line (HCT 116) | Human | USP11 | 1:2~1:4 | Negative | Online Inquiry |
KO04964 | USP11 Knockout cell line (HEK293) | Human | USP11 | 1:3~1:6 | Negative | Online Inquiry |
USP11 Gene Knockout Cell Lines are genetically modified cell lines that have been specifically designed to lack the expression of the ubiquitin-specific peptidase 11 (USP11) gene. This critical gene is involved in various cellular processes, including the regulation of protein degradation, cell cycle control, and the modulation of cellular responses to stress. By creating knockout models where USP11 is non-functional, researchers can explore the physiological and pathological roles of USP11, providing insight into its contributions to cellular homeostasis and disease mechanisms.
The key mechanism of action for these knockout cell lines relies on CRISPR/Cas9 technology, which facilitates precise editing of the genomic DNA at the USP11 locus. By deleting this gene, researchers can effectively elucidate the downstream effects on cellular pathways, allowing for in-depth studies into processes such as apoptosis, inflammation, and tumorigenesis. This model is invaluable for investigating the potential therapeutic implications of USP11, particularly in cancer research, autoimmune disorders, and neurodegenerative diseases.
The scientific importance of USP11 Gene Knockout Cell Lines is underscored by their application in both basic research and translational studies. Researchers can employ these cell lines to uncover novel biological functions of USP11 and validate its role as a potential drug target. Their utility extends to drug screening assays, biomarker discovery, and understanding the molecular underpinnings of diseases linked to aberrant USP11 activity.
Compared to alternative models, USP11 knockout cell lines offer several advantages, including higher specificity in gene targeting and the potential to study effects in a relevant cellular context. Unlike chemical inhibitors or overexpression systems that may produce off-target effects, these knockout lines provide a clear and direct assessment of the loss-of-function phenotype associated with USP11.
For researchers and clinicians alike, the value of USP11 Gene Knockout Cell Lines lies in their capacity to unlock new avenues for scientific inquiry and therapeutic intervention. By providing a reliable tool for gene functional studies, these knockout lines enable stakeholders to accelerate their research and contribute to the advancement of medical science.
Our company specializes in the development of high-quality genetic models and offers a comprehensive suite of customizable biological products designed to meet the diverse needs of today’s researchers. With our expertise in gene editing technologies, we are committed to supporting innovative research and enhancing scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.